Angiodynamics (ANGO) Receivables (2011 - 2026)

Angiodynamics has reported Receivables for 16 years, with the latest figure at $45.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 4.79% year-over-year to $45.6 million; the trailing twelve-month figure through Feb 2026 stood at $45.6 million (up 4.79% YoY), and the FY2025 full-year result was $42.9 million, down 1.65% from the prior year.
• Receivables for Q1 2026 stood at $45.6 million, up from $44.4 million in the prior quarter.
• The five-year high for Receivables was $53.6 million in Q3 2022, with the low at $39.6 million in Q3 2024.
• Historically, Receivables has averaged $47.1 million across 5 years, with a median of $45.6 million in 2026.
• Annual changes were most pronounced in 2022 — Receivables soared 51.3% — and 2024, when it fell 20.48%.
• Angiodynamics' Receivables stood at $52.9 million in 2022, then dropped by 2.36% to $51.6 million in 2023, then fell by 16.37% to $43.2 million in 2024, then advanced by 2.96% to $44.4 million in 2025, then gained by 2.52% to $45.6 million in 2026.
• The last three Receivables figures came in at $45.6 million (Q1 2026), $44.4 million (Q4 2025), and $42.6 million (Q3 2025), per Business Quant data.